Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 56 of the 58 references it cites were found in a registry or an index.

Biomimetic Human Disease Model of SARS‐CoV‐2‐Induced Lung Injury and Immune Responses on Organ Chip System

Open access
Zhang, Min, Wang, Peng, Luo, Ronghua, Wang, Yaqing, Li, Zhongyu, Guo, Yaqiong, Yao, Yulin, Li, Minghua, Tao, Tingting, Chen, Wenwen, Han, Jianbao, Liu, Haitao, Cui, Kangli, Zhang, Xu, Zheng, Yongtang, Qin, Jianhua · 2021 · Advanced Science

Published version of a preprint

Abstract

Coronavirus disease 2019 (COVID‐19) is a global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). The models that can accurately resemble human‐relevant responses to viral infection are lacking. Here, a biomimetic human disease model on chip that allows to recapitulate lung injury and immune responses induced by SARS‐CoV‐2 in vitro at organ level is created. This human alveolar chip reproduce the key features of alveolar‐capillary barrier by coculture of human alveolar epithelium, microvascular endothelium, and circulating immune cells under fluidic flow in normal and disease. Upon SARS‐CoV‐2 infection, the epithelium exhibits higher susceptibility to virus than endothelium. Transcriptional analyses show activated innate immune responses in epithelium and cytokine‐dependent pathways in endothelium at day 3 post‐infection, revealing the distinctive responses in different cell types. Notably, viral infection causes the immune cell recruitment, endothelium detachment, and increased inflammatory cytokines release, suggesting the crucial role of immune cells involved in alveolar barrier injury and exacerbated inflammation. Treatment with remdesivir can inhibit viral replication and alleviate barrier disruption on chip. This organ chip model can closely mirror human‐relevant responses to SARS‐CoV‐2 infection, which is difficult to be achieved by in vitro models, providing a unique platform for COVID‐19 research and drug development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/advs.202002928

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Schematic diagram of microengineered human alveolus chip infected by SARS‐CoV‐2. A) Illustration of 3D human alveolar‐capillary barrier in vivo. B) The configuration of biomimetic human alveolus chip infected by SARS‐CoV‐2. The device consists of upper alveolar epithelial channel (blue) and lower pulmonary microvascular endothelial channel (red) separated by a porous PDMS membrane. The alveolar‐capillary interface is formed by coculture of alveolar epithelial cells (HPAEpiC) and pulmonary microvascular endothelial cells (HULEC‐5a) on chip under fluid flow conditions. The established alveolus chip is exposed to SARS‐CoV2 on the epithelial layer. Human immune cells are infused into the bottom vascular channel during the progression of virus infection. C) The responses of human alveolus chip to SARS‐CoV‐2 are analyzed using different methods.
Figure 1 Schematic diagram of microengineered human alveolus chip infected by SARS‐CoV‐2. A) Illustration of 3D human alveolar‐capillary barrier in vivo. B) The configuration of biomimetic human alveolus chip infected by SARS‐CoV‐2. The device consists of upper alveolar epithelial channel (blue) and lower pulmonary microvascular endothelial channel (red) separated by a porous PDMS membrane. The alveolar‐capillary interface is formed by coculture of alveolar epithelial cells (HPAEpiC) and pulmonary microvascular endothelial cells (HULEC‐5a) on chip under fluid flow conditions. The established alveolus chip is exposed to SARS‐CoV2 on the epithelial layer. Human immune cells are infused into the bottom vascular channel during the progression of virus infection. C) The responses of human alveolus chip to SARS‐CoV‐2 are analyzed using different methods.CC BY · PubMed Central
Figure 2 Examination of SARS‐CoV‐2 infection in HPAEpiC cells. A) Analysis of ACE2 and TMPRSS2 proteins expression levels in HPAEpiC and HULEC‐5a cells by western blot. The results are representative blot from three experiments. GAPDH is served as a loading control. B) Analysis of ACE2, TMPRSS2, and viral nucleoprotein (NP) expression levels in mock‐ or SARS‐CoV‐2‐infected cells at day 3 post‐infection. The results are representative blot from three independent experiments. C) Immunofluorescent images showed the viral Spike protein (Spike protein S1 subunit of SARS‐CoV‐2) staining in HPAEpiC cells at day 3 post‐infection. C) TEM images of mock HPAEpiC cells without virus infection. i) The overall image of HPAEpiC cell. ii) The enlarged image of microvilli on free surface of HPAEpiC cell. iii) The enlarged image of lamellar bodies (LB) within cell body. D) TEM images of SRAS‐CoV‐2‐infected HPAEpiC cells. i) The overall image of the infected cell. ii) Clusters of viruses within cell body. iii) Enlarged image of virus particles. Three independent experiments were performed (n = 3).
Figure 2 Examination of SARS‐CoV‐2 infection in HPAEpiC cells. A) Analysis of ACE2 and TMPRSS2 proteins expression levels in HPAEpiC and HULEC‐5a cells by western blot. The results are representative blot from three experiments. GAPDH is served as a loading control. B) Analysis of ACE2, TMPRSS2, and viral nucleoprotein (NP) expression levels in mock‐ or SARS‐CoV‐2‐infected cells at day 3 post‐infection. The results are representative blot from three independent experiments. C) Immunofluorescent images showed the viral Spike protein (Spike protein S1 subunit of SARS‐CoV‐2) staining in HPAEpiC cells at day 3 post‐infection. C) TEM images of mock HPAEpiC cells without virus infection. i) The overall image of HPAEpiC cell. ii) The enlarged image of microvilli on free surface of HPAEpiC cell. iii) The enlarged image of lamellar bodies (LB) within cell body. D) TEM images of SRAS‐CoV‐2‐infected HPAEpiC cells. i) The overall image of the infected cell. ii) Clusters of viruses within cell body. iii) Enlarged image of virus particles. Three independent experiments were performed (n = 3).CC BY · PubMed Central
Figure 3 Characterization of infection and replication of SARS‐CoV‐2 in human alveolus chip. A) 3D reconstructed confocal image of alveolar epithelium (E‐cadherin) and pulmonary microvascular endothelium (VE‐cadherin) in the alveolus chip. B) Side view of alveolar epithelium (E‐cadherin) and pulmonary microvascular endothelium (VE‐cadherin). C) 3D reconstructed confocal image of human alveolar‐capillary‐barrier at day 3 post‐infection. D) Side view of the formed alveolar barrier after viral infection. SARS‐CoV‐2 infection was predominantly identified in epithelium layer by viral Spike protein expression. E) Confocal immunofluorescent microscopy images showed the effects of SARS‐CoV‐2 infection (Spike protein) on the human epithelium (E‐cadherin) and endothelium (VE‐cadherin) of chip at day 3 post‐infection. F) Cell confluency of epithelium and endothelium on chip was examined with or without SARS‐CoV‐2 infection. Data were presented as mean ± SD. Three chips were quantified for each group.
Figure 3 Characterization of infection and replication of SARS‐CoV‐2 in human alveolus chip. A) 3D reconstructed confocal image of alveolar epithelium (E‐cadherin) and pulmonary microvascular endothelium (VE‐cadherin) in the alveolus chip. B) Side view of alveolar epithelium (E‐cadherin) and pulmonary microvascular endothelium (VE‐cadherin). C) 3D reconstructed confocal image of human alveolar‐capillary‐barrier at day 3 post‐infection. D) Side view of the formed alveolar barrier after viral infection. SARS‐CoV‐2 infection was predominantly identified in epithelium layer by viral Spike protein expression. E) Confocal immunofluorescent microscopy images showed the effects of SARS‐CoV‐2 infection (Spike protein) on the human epithelium (E‐cadherin) and endothelium (VE‐cadherin) of chip at day 3 post‐infection. F) Cell confluency of epithelium and endothelium on chip was examined with or without SARS‐CoV‐2 infection. Data were presented as mean ± SD. Three chips were quantified for each group.CC BY · PubMed Central
Figure 4 Transcriptional analysis of HPAEpiC cells and HULEC‐5a cells to SARS‐CoV‐2 infection in human alveolus chip. A) Viral replication levels in HPAEpiC and HULEC‐5a cells. The ratio of virus‐aligned reads over total reads is indicated for the viral replication level for each sample. Three independent experiments were performed (n = 3). B) Read coverage of viral reads along the SARS‐CoV‐2 genome for the infected‐HPAEpiC cells or HULEC‐5a cells. The graph indicated the viral reads number per position of the viral genome in the infected‐HPAEpiC cells or HULEC‐5a cells. This graph is representative of three independent experiments. C) Volcano plots showing the regulated genes of cells following SARS‐CoV‐2 infection. Genes differentially expressed with fold change over 2.0 and p < 0.05 were marked in color. P values were calculated using a two‐sided, unpaired Student's t‐test with equal variance assumed (n = 3 independent biological samples). D) Venn diagrams depicting the differentially expressed genes (DEGs) shared or unique between each comparison. E) GO enrichment analysis of DEGs in HPAEpiC cells following SARS‐CoV‐2 infection. F) GO enrichment analysis of DEGs in HULEC‐5a cells following SARS‐CoV‐2 infection. E,F) The color of the dots represents the rich factor and the size represents the input number for each GO term. The horizontal axis indicates the significance of enrichment (−log10 (P value)), and the vertical axis indicates the 20 most enriched GO terms.
Figure 4 Transcriptional analysis of HPAEpiC cells and HULEC‐5a cells to SARS‐CoV‐2 infection in human alveolus chip. A) Viral replication levels in HPAEpiC and HULEC‐5a cells. The ratio of virus‐aligned reads over total reads is indicated for the viral replication level for each sample. Three independent experiments were performed (n = 3). B) Read coverage of viral reads along the SARS‐CoV‐2 genome for the infected‐HPAEpiC cells or HULEC‐5a cells. The graph indicated the viral reads number per position of the viral genome in the infected‐HPAEpiC cells or HULEC‐5a cells. This graph is representative of three independent experiments. C) Volcano plots showing the regulated genes of cells following SARS‐CoV‐2 infection. Genes differentially expressed with fold change over 2.0 and p < 0.05 were marked in color. P values were calculated using a two‐sided, unpaired Student's t‐test with equal variance assumed (n = 3 independent biological samples). D) Venn diagrams depicting the differentially expressed genes (DEGs) shared or unique between each comparison. E) GO enrichment analysis of DEGs in HPAEpiC cells following SARS‐CoV‐2 infection. F) GO enrichment analysis of DEGs in HULEC‐5a cells following SARS‐CoV‐2 infection. E,F) The color of the dots represents the rich factor and the size represents the input number for each GO term. The horizontal axis indicates the significance of enrichment (−log10 (P value)), and the vertical axis indicates the 20 most enriched GO terms.CC BY · PubMed Central
Figure 5 RNA‐seq analysis showed distinctive immune responses to SARS‐CoV‐2 infection in cocultured HPAEpiC cells and HULEC‐5a cells on chip. A) GO enrichment analysis of upregulated DEGs related with immune response in HPAEpiC cells after viral infection. F) GO enrichment analysis upregulated DEGs related with immune response in HULEC‐5a cells after viral infection. C) Upregulated cytokines genes in HPAEpiC cells infected with virus by RNA‐seq analysis. D) Upregulated cytokines genes in HULEC‐5a cells infected with virus by RNA‐seq analysis. Data were analyzed by Student's t‐test (*p < 0.05).
Figure 5 RNA‐seq analysis showed distinctive immune responses to SARS‐CoV‐2 infection in cocultured HPAEpiC cells and HULEC‐5a cells on chip. A) GO enrichment analysis of upregulated DEGs related with immune response in HPAEpiC cells after viral infection. F) GO enrichment analysis upregulated DEGs related with immune response in HULEC‐5a cells after viral infection. C) Upregulated cytokines genes in HPAEpiC cells infected with virus by RNA‐seq analysis. D) Upregulated cytokines genes in HULEC‐5a cells infected with virus by RNA‐seq analysis. Data were analyzed by Student's t‐test (*p < 0.05).CC BY · PubMed Central
Figure 6 Distinctive responses of cocultured epithelium and endothelium to SARS‐CoV‐2 infection in the presence or absence of circulating immune cells. A) Confocal images showed the effects of SARS‐CoV‐2 infection (Spike) on the epithelium (E‐cadherin) and endothelium (VE‐cadherin) with or without immune cells (PBMCs) at day 2 post‐infection. B,C) Quantifications of cell confluency following SARS‐CoV‐2 infection in the presence or absence of circulating immune cells (PBMCs). Three chips were quantified for each group. Data were analyzed using a one‐way ANOVA with Bonferroni post‐test (*p < 0.05). D) Confocal immunofluorescent microscopy images showed the recruitment and adhesion of PBMCs (red) on the surface of HULEC‐5a layer (green) after SARS‐CoV‐2 infection. E) Confocal immunofluorescent microscopy images showed the recruitment and adhesion of CD14+ monocytes (red) on the surface of HULEC‐5a cell layer (green) after SARS‐CoV‐2 infection. F–I) Quantitative analysis of released inflammation cytokines IL‐1β, IL‐6, IL‐8, and TNF‐α from the culture medium in vascular channel under different conditions. Data were presented as mean ± SD. Data were analyzed using a one‐way ANOVA with Bonferroni post‐test (***p < 0.001). Six chips were quantified for each group.
Figure 6 Distinctive responses of cocultured epithelium and endothelium to SARS‐CoV‐2 infection in the presence or absence of circulating immune cells. A) Confocal images showed the effects of SARS‐CoV‐2 infection (Spike) on the epithelium (E‐cadherin) and endothelium (VE‐cadherin) with or without immune cells (PBMCs) at day 2 post‐infection. B,C) Quantifications of cell confluency following SARS‐CoV‐2 infection in the presence or absence of circulating immune cells (PBMCs). Three chips were quantified for each group. Data were analyzed using a one‐way ANOVA with Bonferroni post‐test (*p < 0.05). D) Confocal immunofluorescent microscopy images showed the recruitment and adhesion of PBMCs (red) on the surface of HULEC‐5a layer (green) after SARS‐CoV‐2 infection. E) Confocal immunofluorescent microscopy images showed the recruitment and adhesion of CD14+ monocytes (red) on the surface of HULEC‐5a cell layer (green) after SARS‐CoV‐2 infection. F–I) Quantitative analysis of released inflammation cytokines IL‐1β, IL‐6, IL‐8, and TNF‐α from the culture medium in vascular channel under different conditions. Data were presented as mean ± SD. Data were analyzed using a one‐way ANOVA with Bonferroni post‐test (***p < 0.001). Six chips were quantified for each group.CC BY · PubMed Central
Figure 7 Evaluation of potential antiviral efficacy of remdesivir on the chip system. A) Culture supernatants were harvested at indicated time points following SARS‐CoV‐2 infection to examine the viral load using qRT‐PCR for different groups. The average of two independent experiments is shown. Data were presented as mean ± SD. B) Confocal immunofluorescent microscopy images of epithelium (E‐cadherin) and endothelium (VE‐cadherin) of alveolus chip treated without or with 1 × 10−6 m remdesivir at day 2 post‐infection. C) Quantification for epithelial cell confluency of alveolus chip treated without or with 1 × 10−6 m remdesivir at day 2 post‐infection. Three chips were quantified for each group. Data were analyzed by Student's t‐test (*p < 0.05).
Figure 7 Evaluation of potential antiviral efficacy of remdesivir on the chip system. A) Culture supernatants were harvested at indicated time points following SARS‐CoV‐2 infection to examine the viral load using qRT‐PCR for different groups. The average of two independent experiments is shown. Data were presented as mean ± SD. B) Confocal immunofluorescent microscopy images of epithelium (E‐cadherin) and endothelium (VE‐cadherin) of alveolus chip treated without or with 1 × 10−6 m remdesivir at day 2 post‐infection. C) Quantification for epithelial cell confluency of alveolus chip treated without or with 1 × 10−6 m remdesivir at day 2 post‐infection. Three chips were quantified for each group. Data were analyzed by Student's t‐test (*p < 0.05).CC BY · PubMed Central
Figure 8 Schematic summary of SARS‐CoV‐2‐induced lung injury and inflammatory responses associated with COVID 19 on the human organ chip model system. Following SARS‐CoV‐2 exposure, virus particles invade the alveolar epithelium and endothelium and replicate violently in human epithelial cells. The viral infection can activate the host antiviral defense or immune response, including the activation of innate immune responses (e.g., IFN‐I signaling pathway) in epithelial cells and JAK‐STAT signaling pathway in endothelial cells. The cytokines or chemokines released from infected cells can recruit circulating immune cells (such as CD14+ monocytes) to infected sites and initiate inflammatory responses. This process further exacerbates the disruption of alveolus‐capillary barrier integrity, leading to lung injury.
Figure 8 Schematic summary of SARS‐CoV‐2‐induced lung injury and inflammatory responses associated with COVID 19 on the human organ chip model system. Following SARS‐CoV‐2 exposure, virus particles invade the alveolar epithelium and endothelium and replicate violently in human epithelial cells. The viral infection can activate the host antiviral defense or immune response, including the activation of innate immune responses (e.g., IFN‐I signaling pathway) in epithelial cells and JAK‐STAT signaling pathway in endothelial cells. The cytokines or chemokines released from infected cells can recruit circulating immune cells (such as CD14+ monocytes) to infected sites and initiate inflammatory responses. This process further exacerbates the disruption of alveolus‐capillary barrier integrity, leading to lung injury.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 58 references

Research works printed but not linked: 7

  1. Han Y., 2020, bioRxiv
  2. Suzuki T., 2020, bioRxiv
  3. Si L., 2020, bioRxiv
  4. Si L., 2019, bioRxiv
  5. Qin X., 2013, Biomed. Res. Int., 2013, 240659
  6. Williamson B. N., 2020, bioRxiv
  7. Conti P., 2020, J. Biol. Regul. Homeostatic Agents, 34, 327

Cited by

See all 236

Metadata

Authors
Zhang, M., Wang, P., Luo, R., Wang, Y., Li, Z., Guo, Y., Yao, Y., Li, M., Tao, T., Chen, W., Han, J., Liu, H., Cui, K., Zhang, X., Zheng, Y., & Qin, J.
Affiliations
  • Dalian Institute of Chemical Physics (CN)
  • Kunming National High‐Level Bio‐safety Research Center for Non‐human Primates Center for Biosafety Mega‐Science Kunming Institute of Zoology Chinese Academy of Sciences Kunming 650107 China
  • Kunming Institute of Zoology (CN)
Corresponding author
Qin, Jianhua
Venue
Advanced Science
Publisher
Wiley
Published
2020-12-21
Volume
8
Issue
3
Pages
2002928-2002928
ISSN
2198-3844 (ISSN-L)
OpenAlex
W3093526172
Cited by
236
References
58
Citations by year
2026: 23 · 2025: 33 · 2024: 46 · 2023: 61 · 2022: 38 · 2021: 34 · 2020: 1
FWCI
10.52
Type
journal article
Language
en
Open access
Locations
  • Advanced Science (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Key Research and Development Program of China (2020YFC0842000)
  • Yunnan Key Research and Development Program (202003AD150009)
  • China Postdoctoral Science Foundation (2019M660065)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Keywords
SARS-CoV-2, COVID-19 pandemic, lung injury, organ-on-a-chip, alveolar-capillary barrier, alveolar epithelium, microvascular endothelium, immune cell recruitment, innate immune response, cytokine production, remdesivir, antiviral drug testing, disease models

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Biomimetic Human Disease Model of SARS‐CoV‐2‐Induced Lung Injury and Immune Responses on Organ Chip System. https://app.cochat.ai/papers/10.1002/advs.202002928
The paper
Zhang, M., Wang, P., Luo, R., Wang, Y., Li, Z., Guo, Y., Yao, Y., Li, M., Tao, T., Chen, W., Han, J., Liu, H., Cui, K., Zhang, X., Zheng, Y., & Qin, J. (2021). Biomimetic Human Disease Model of SARS‐CoV‐2‐Induced Lung Injury and Immune Responses on Organ Chip System. Advanced Science. https://doi.org/10.1002/advs.202002928

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.